Global Bioinformatics Market Size, Product Type (Sequencing Platforms, Knowledge Management Tools, Bioinformatics Software), Applications (Genomics, Proteomics & Metabolomics), & Sectors (Medical, Academics, Agriculture), By Region (North America, Europe, Asia Pacific, South America, and the Middle East & Africa), Trend Analysis, Competitive Market Share & Forecast, 2016-2026

Published:
January 2021
Report Code:
bwc20158
Available Format:
PDF PDF Icon
Pages:
186

global bioinformatics market bwc20158

Global Bioinformatics Market Size - Industry Trends & Outlook Report 2026

Development of the bioinformatics market is determined by the rising request for nucleic acid and protein sequencing, growing government edges and backing, and growing use of bioinformatics in drug discovery and biomarker development processes. With the outline of upcoming types of machinery such as nanopore sequencing (third-generation sequencing technique) and cloud calculating, the market is expected to offer noteworthy opportunities for manufacturers of bioinformatics solutions. Though, issues such as a shortage of skilled personnel to ensure the right use of bioinformatics tools and lack of integration of a large variety of data generated through many bioinformatics platforms are obstructing the market growth.

 

Global Bioinformatics Market: Market Outlook and Trends

 

Bioinformatics is a combination of information technology and biology, which links biological data with methods for information storage, spreading, and inspection to upkeep various areas of scientific research, counting biomedicine. It uses software tools for file creation, data management, data warehousing, data withdrawal, and others. Mining these data leads to scientific detections, which are used in the study of heredities & genomes. Several bioinformatics tools are obtainable in the market. They are categorized as protein functional & analysis tools, homology & resemblance tools, sequence examination tools, and miscellaneous tools. The field covers many advanced and specialized areas of life, such as structural genomics, functional genomics, DNA microarrays, relative genomics, medical facts, and others. Hence, these factors mentioned above help in growing the worldwide bioinformatics market share.

 

Global Bioinformatics Market

 

Growth Drivers 

 

Growing demand for nucleic acid and protein sequencing due to reductions in sequencing costs and technological advancements

 

Bioinformatics is progressively being used to recognize genes in DNA sequences. The information collected is used to know the molecular mechanisms of diseases. This assists in developing better treatments and diagnostic tests. Due to important discounts on costs of sequencing, many scientific research institutes and biotechnology companies have undertaken initiatives to perform sequencing studies at their amenities. Similarly, sequencing and data analysis and clarification can now be finished within days after the growth of quicker and sophisticated bioinformatics tools. With progressions in technology, there has been a surge in the speed of translating genetic sequences, which has decreased the complete cost of sequencing and analysis per sample. The reasons behind this reduction in cost include the growth of advanced DNA sequencing platforms and various bioinformatics tools.

 

Increasing funding will drive the growth of the market

 

IT giants have started focusing on bioinformatics for healthcare applications. Investments are being made for more advanced tests and techniques in battling diseases such as cancer and Parkinson’s. Microsoft co-founder Bill Gates and Amazon founder Jeff Bezos have invested millions of dollars in Grail, a start-up by gene sequencing firm Illumina that a former Google executive lead. Grail is emerging a cancer-screening blood test for persons, even if they show no indications. The test’s development is foreseeable to require many samples to be sequenced and inspected by using more whole bioinformatics tools and databases.

 

Impact of COVID-19 in industry

 

COVID-19 has had an influence on economies – and segments within those economies. Some industries have struggled, and others have started to flourish. One of those where there has been a vital move in development is bioinformatics. As a result, this market is now estimated to grow meaningfully, not just during the residual months in which COVID-19 is a leading factor but in the post-COVID retrieval period too.

 

Global Bioinformatics Market: Segmentation

 

By Product Type, the bioinformatics stages section is expectable to be the firmest-rising section in the prediction period. Knowledge management tools demanded the major market share in the global bioinformatics market in 2018, while the bioinformatics platforms section is foreseeable to be the fastest-rising section in the prediction period. The main issue driving the growth of bioinformatics platforms is their growing use in many genomic applications. In addition, the use of bioinformatics platforms is growing in the drug discovery & growth process, which is causal to market growth. Though, the lack of standardization in bioinformatics platforms through the industry is restrictive development of the bioinformatics platforms market, due to which bioinformatics professionals must work with fluctuating standards and platforms that give no reproducible results.

 

By Application, the metabolomics section is predictable to produce at the highest CAGR during the prediction period. Factors such as the obtainability of research funding and government support are driving market growth. However, metabolomes cannot be easily identified or figured from reconstructed biochemical trails due to enzymatic variety, substrate ambiguity, and the difference in governing mechanisms. Hence, the annotation of unidentified metabolic signals is the main interruption to the growth of the metabolomics section.

 

By Sector, the medical biotechnology segment is expected to grow at the highest CAGR during the forecast period. Numerous pharmaceutical companies are progressively accepting bioinformatics tools to decline the cost and time involved in drug discovery. Bioinformatics methods for target detection and authentication are proving more competent than old-style methods. With the help of bioinformatics tools, much of the information concerning drug candidates is authenticated at a molecular level, which inclines to decrease drug attrition rate in the later stages of drug development. Thus, donating to the success of more drug candidates in the clinical trials is making the drug growth progression more cost actual. Geographically, the Bioinformatics market has been separated into North America, Europe, Asia Pacific, South America, and the Middle East & Africa.

 

Global Bioinformatics Market: Regional Insights 

 

The market in the Asia Pacific region is predictable to propose noteworthy chances for players to offset income losses sustained in established markets. Developing countries in this region are watching development in their GDPs and an essential increase in disposable income levels. This has led to augmented healthcare disbursements by a more extensive population base, healthcare infrastructure innovation, and rising diffusion of cutting-edge research and clinical laboratory technologies, counting bioinformatics, in Asia Pacific countries. These issues are predictable to provide noteworthy growth chances to bioinformatics companies working in this region.

 

Competitive Landscape

 

The leading players in the Bioinformatics Market include Agilent Technologies, Inc., Geneva Bioinformatics (Genebio), Dassault Systems, Eurofins Scientific, Illumina Inc., Bruker Daltonics Inc., Biomax Informatics AG, Perkinelmer Inc., Qiagen N.V, and Thermo Fisher Scientific, Inc. The other players in the value chain include Accelrys, Inc., Affymetrix, Inc., SA Nonlinear Dynamics, Quest Diagnostics, Inc., and others.

Recent Developments

Ø  In April 2019, The HANS-GINS Indxx Healthcare Innovation Ucits ETF will focus on developments in sectors including bioinformatics, bioengineering, genome sequencing, healthcare trackers, nanotechnology, neuroscience, robotics and medical devices.

Ø  In March 2017, Agilent Technologies Inc. introduced its first comparative genomic hybridization (CGH) assay which will be used for diagnostic purposes: the GenetiSureDx Postnatal Assay. This will help the clinical geneticists to detect genetic anomalies early with more accuracy as compared to than traditional methods.

 

Scope of Report

Attribute

Details

Years Considered

Historical data – 2016-2018

Base Year – 2019

Forecast – 2020 – 2026

Facts Covered

Revenue in USD Billion

Market Coverage

U.S, Canada, Germany, UK, France, Italy, Spain, Brazil, Mexico, Japan, South Korea, China, India, UAE, South Africa, Saudi Arabia .

Product/Service Segmentation

By Product Type, By Application, By Sectors, By Region

Key Players

The leading players considered for market analysis are Agilent Technologies, Inc., Geneva Bioinformatics (Genebio), Dassault Systems, Eurofins Scientific, Illumina Inc., Bruker Daltonics Inc., Biomax Informatics AG, Perkinelmer Inc., Qiagen N.V, and Thermo Fisher Scientific, Inc. The other players in the value chain include Accelrys, Inc., Affymetrix, Inc., SA Nonlinear Dynamics, Quest Diagnostics, Inc., and others.

 

 

Ø  By Product Type

o    Sequencing platforms

ü  Sequence Analysis Platforms

ü  Sequence Alignment Platforms

ü  Sequence Manipulation Platforms

ü  Structural Analysis Platforms

ü  Others

o    Knowledge management tools

ü  Generalized Knowledge Management Tools

ü  Specialized Knowledge Management Tool

o    Bioinformatics software.

 

·          By Application

ü  Genomics

ü  Proteomics & Metabolomics

·         By Sectors

ü  Medical

ü  Academics

ü  Agriculture

·         By Region

ü  North America

ü  Europe

ü  Asia Pacific

ü  South America

ü  Middle East & Africa

 

The objective of the Study:

• To analyze and forecast the Global Bioinformatics Market size of the market in terms of value.

• To examine the careful market segmentation and forecast the market size, in terms of value, based on the region by segmenting.

• The Global Bioinformatics Market into five regions, namely, North America, Europe, Asia Pacific, Middle East, South America, and their leading countries.

• To outline, categorized, and forecast the Global Bioinformatics Market based on the By Product Type, By Application, By Sectors, and By Regional.

• To examine competitive developments, like By Products Type, By Application, By Sectors, By Regional within the Global Bioinformatics Market.

• To highlight the impact analysis of the factors affecting the market dynamics such as growth drivers.

• To strategically profile the key players and comprehensively analyze their market shares along with detailing the competitive landscape for market leaders.

 

Business Questions Answer by the Report

Ø  How will the market drivers, restraints, and opportunities affect the market dynamics?

Ø  What will be the market size in terms of value and volume and market statistics with a detailed classification?

Ø  Which segment dominates the market or region, and one will be the fastest - growing, and why?

Ø  A comprehensive survey of the competitive landscape and the market participant players

Ø  Analysis of strategy adopted by the key player and their impact on other players.

Customization Scope for the Client

Client satisfaction is our first and last priority, and that is why BlueWeave Consulting offers customization according to Company’s specific needs. The following customization options are available for the report:

Additional Company Information

•    With five additional company detail analysis

•    Additional country analysis

•    Detailed segment analysis

COVID-19

We've been tracking the direct impact of COVID-19 on this market, and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Contact our sales team for more details at

Contact Now

WHY CHOOSE US

  • 24/7 Research support

    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Coustom Research Service

    Ask the Analyst to customize an exclusive study to serve your research needs.

  • Quality & Accuracy

    offers best quality reports based on various authentic and accurate data findings.

  • Data Visualization

    As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization

  • Information security

    We never share your personal and confidential information. Your personal information is safe and secure with us.